Gao Y J, Nishimura Y, Suzuki A, Higashino H
Department of Pharmacology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.
J Smooth Muscle Res. 1999 Aug;35(4):125-34. doi: 10.1540/jsmr.35.125.
The reactivity of intrarenal arteries to vasoconstrictor and vasodilator polypeptides was examined in adult stroke-prone spontaneously hypertensive rats (SHRSP). The contraction response to endothelin-1 (ET-1) was greater in SHRSP than in age-matched Wistar-Kyoto rats (WKY), and so was the pD2 estimate (8.05+/-0.03 in SHRSP, and 7.73+/-0.06 in WKY; n=5, P < 0.05). The contraction response to, and the pD2 estimate of, vasopressin were comparable in SHRSP and WKY. Neuropeptide Y did not contract the intrarenal arteries. In norepinephrine-precontracted arteries with intact endothelium, substance P and neurokinin A did not relax the arteries of either SHRSP or WKY, while calcitonin gene-related peptide (CGRP) induced a profound relaxation response. Relaxation response to CGRP was significantly greater in SHRSP than in WKY. Atrial, brain, and C-type natriuretic peptides (ANP, BNP, CNP), vasoactive intestinal polypeptide (VIP), and peptide histidine isoleucine (PHI) all caused relaxation responses, with a greater extent of relaxation to ANP, BNP, and VIP and a less extent to CNP and PHI. However, there were no significant differences in these relaxation responses between SHRSP and WKY. The current results revealed the character of heterogeneity of rat intrarenal arteries in response to vasoconstrictor and vasodilator peptides, and showed an enhanced reactivity to ET-1 and to CGRP in SHRSP.
在成年易患中风的自发性高血压大鼠(SHRSP)中检测了肾内动脉对血管收缩和舒张多肽的反应性。与年龄匹配的Wistar-Kyoto大鼠(WKY)相比,SHRSP对内皮素-1(ET-1)的收缩反应更大,pD2估计值也是如此(SHRSP为8.05±0.03,WKY为7.73±0.06;n = 5,P < 0.05)。SHRSP和WKY对血管加压素的收缩反应及其pD2估计值相当。神经肽Y不会使肾内动脉收缩。在去甲肾上腺素预收缩且内皮完整的动脉中,P物质和神经激肽A不会使SHRSP或WKY的动脉舒张,而降钙素基因相关肽(CGRP)可诱导显著的舒张反应。SHRSP对CGRP的舒张反应明显大于WKY。心房、脑和C型利钠肽(ANP、BNP、CNP)、血管活性肠肽(VIP)和肽组氨酸异亮氨酸(PHI)均引起舒张反应,对ANP、BNP和VIP的舒张程度较大,对CNP和PHI的舒张程度较小。然而,SHRSP和WKY之间这些舒张反应没有显著差异。目前的结果揭示了大鼠肾内动脉对血管收缩和舒张肽反应的异质性特征,并表明SHRSP对ET-1和CGRP的反应性增强。